Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kibur Microdevice in Early Stage Breast Cancer
NCT02521363Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2015
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Open-label trial in breast cancer (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Number of Participants With Implantable Devices up to 1 year. Started Jul 2015; status: completed.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02521363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02521363.